Craft

Exagen

Stock Price

$2.6

2024-10-29

Market Capitalization

$45 M

2024-10-29

Revenue

$66.6 M

FY, 2025

Exagen Summary

Company Summary

Overview
Exagen is a biotechnology company engaged in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. The company is the provider of AVISE testing, offering physicians diagnostic, prognostic and monitoring tools in the area of rheumatology and autoimmune diseases.
Type
Public
Status
Active
Founded
2002
HQ
Vista, CA, US | view all locations
Website
http://www.exagen.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

Operating MetricsView all

Medical Tests Delivered (AVISE)

50.8K

Q2, 2019

Physicians Reached

1.7K

Q2, 2019

Medical Tests Delivered Since Inception (AVISE)

326K

Q2, 2019

LocationsView all

1 location detected

  • Vista, CA HQ

    United States

    1261 Liberty Way

Exagen Financials

Summary Financials

Revenue (Q1, 2026)
$17.3M
Gross profit (Q1, 2026)
$10.2M
Net income (Q1, 2026)
($4.0M)
Cash (Q1, 2026)
$21.5M
EBIT (Q1, 2026)
($3.4M)
Enterprise value
$49.6M

Footer menu